Aantal gebruikers 2019-2023 voor ATC-subgroep A10BJ : Glucagonachtig peptide-1-agonisten (glp-1-agonisten)
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| A10BJ01 Exenatide | 746 | 585 | 477 | 410 | 98 |
| A10BJ02 Liraglutide (Saxenda ®) | 11.700 | 9.893 | 8.328 | 16.665 | 23.675 |
| A10BJ03 Lixisenatide (Lyxumia ®) | 149 | 101 | 66 | 63 | 159 |
| A10BJ05 Dulaglutide (Trulicity ®) | 3.357 | 4.566 | 5.472 | 9.841 | 8.491 |
| A10BJ06 Semaglutide (Ozempic ®) | 12.095 | 26.153 | 42.219 | 62.396 | 89.345 |